Chicago, IL, United States of America

Martha C Bohn

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 101(Granted Patents)


Company Filing History:


Years Active: 2008-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Martha C Bohn: Innovator in Gene Therapy

Introduction

Martha C Bohn is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of gene therapy, holding a total of 3 patents. Her work focuses on innovative methods for gene delivery and gene silencing, which have important implications for treating neurological disorders.

Latest Patents

One of her latest patents is titled "siRNA-mediated gene silencing of synuclein." This invention is directed to small interfering RNAs that downregulate the expression of a synuclein gene, along with methods for utilizing these small interfering RNAs. Another notable patent is "Tetracycline-regulated adeno-associated viral (AAV) vectors for gene delivery to the nervous system." This patent describes a vector and method for delivering nucleic acids to nervous system cells, utilizing a tetracycline-off regulatable promoter system to control gene expression.

Career Highlights

Martha has worked at esteemed institutions such as Children's Memorial Hospital and Ann & Robert Lurie Children's Hospital of Chicago. Her experience in these organizations has allowed her to advance her research and contribute to the field of pediatric medicine.

Collaborations

Throughout her career, Martha has collaborated with notable colleagues, including Lixin Jiang and Neva C West. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Martha C Bohn is a trailblazer in the field of gene therapy, with a focus on innovative solutions for gene delivery and silencing. Her contributions continue to influence advancements in medical science and offer hope for future treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…